Tuesday, August 26, 2008 8:34:58 PM
This company is an undiscovered gem. Only 8 1/2 million shares in the O/S, no debt and over 20% annual growth over the last 5 years. It isn't covered by any analysts (a plus from my point of view) With the stock price down where it is, it looks like a bargain.
Bolt Technology
Seismic equipment developer Bolt Technology's impressive fundamentals -- strong cash flow, high earnings growth, and zero debt -- have made it a big star among CAPS members. The company acquired Real Time Systems last year, and the acquisition has already contributed more than 15% to its earnings in the first nine months of its fiscal year. Management expects fiscal 2008 to be another record earnings year for the company.
Bolt Technology
Seismic equipment developer Bolt Technology's impressive fundamentals -- strong cash flow, high earnings growth, and zero debt -- have made it a big star among CAPS members. The company acquired Real Time Systems last year, and the acquisition has already contributed more than 15% to its earnings in the first nine months of its fiscal year. Management expects fiscal 2008 to be another record earnings year for the company.
Recent BOLT News
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 03/12/2026 08:14:51 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/12/2026 08:07:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/12/2026 08:05:29 PM
- Bolt Biotherapeutics Reports Fourth Quarter and Full-Year 2025 Financial Results and Provides Business Update • GlobeNewswire Inc. • 03/12/2026 08:05:00 PM
- Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend] • Edgar (US Regulatory) • 02/27/2026 12:22:05 AM
- Bolt Biotherapeutics to Participate in Upcoming March Conferences • GlobeNewswire Inc. • 02/24/2026 01:00:00 PM
- Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend] • Edgar (US Regulatory) • 02/18/2026 01:11:16 AM
- Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 02/13/2026 11:48:34 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/04/2026 09:32:38 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/04/2026 09:32:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/16/2025 10:14:10 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/12/2025 09:08:06 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/12/2025 09:05:28 PM
- Bolt Biotherapeutics Reports Third Quarter 2025 Financial Results and Provides Business Update • GlobeNewswire Inc. • 11/12/2025 09:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/24/2025 11:19:22 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/24/2025 11:18:29 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/02/2025 08:05:26 PM
- Bolt Biotherapeutics Provides Update on BDC-4182 and Extends Cash Runway into 2027 • GlobeNewswire Inc. • 10/01/2025 08:05:00 PM
- Bolt Biotherapeutics Reports Second Quarter 2025 Financial Results and Provides Business Update • GlobeNewswire Inc. • 08/14/2025 08:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/02/2025 08:05:36 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/06/2025 08:39:59 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/04/2025 08:05:10 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/12/2025 08:08:28 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/12/2025 08:05:11 PM
- Bolt Biotherapeutics Reports First Quarter 2025 Financial Results and Provides Business Update • GlobeNewswire Inc. • 05/12/2025 08:05:00 PM
